SCHEMBL21283103

SCHEMBL21283103

CC(F)CCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15160181 0.88
SCHEMBL23904604 0.88
SCHEMBL9226316 0.88 DNM1 (0.44)
SCHEMBL21846682 0.80
SCHEMBL30110429 0.79 LMNA (0.37)
SCHEMBL13109488 0.79
SCHEMBL675740 0.78
SCHEMBL16297588 0.77
SCHEMBL24264517 0.75
SCHEMBL7646987 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340712-A1 POLYMER COMPRISING MULTIPLE FUNCTIONALIZED SIDECHAINS FOR BIOMOLECULE DELIVERY GENEDIT INC. 2022-10-27 US disclosed
EP-3976015-A1 POLYMER COMPRISING MULTIPLE FUNCTIONALIZED SIDECHAINS FOR BIOMOLECULE DELIVERY Genedit Inc. (US) 2022-04-06 EP disclosed
WO-2020243370-A1 POLYMER COMPRISING MULTIPLE FUNCTIONALIZED SIDECHAINS FOR BIOMOLECULE DELIVERY GENEDIT INC. (US) 2020-12-03 WO disclosed
WO-2019161224-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS GiraFpharma LLC (US) 2019-08-22 WO disclosed